Diabetes Mellitus  >>  colesevelam  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
colesevelam / Generic mfg.
NCT00476710: Effects of Colesevelam HCl On Bile Acid Kinetics

Completed
N/A
36
US
Colesevelam HCl
KineMed, Daiichi Sankyo, Inc., University Medical Center Groningen, Diabetes & Glandular Disease Research Associates
Type 2 Diabetes Mellitus, Impaired Glucose Tolerance
04/09
04/09
NCT00596427: Mechanisms of Glucose Lowering Effect of Colesevelam HCl

Completed
N/A
60
US
Colesevelam HCL, WelChol, Placebo
Carine Beysen
Diabetes
04/09
04/09
NCT00938405: Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus

Completed
N/A
45
US
Colesevelam HCl, WELCHOL (colesevelam hydrochloride), Initial U.S. Approval: 2000, Placebo
University of Colorado, Denver, Daiichi Sankyo, Inc.
Diabetes Mellitus, Type 1, Hyperlipidemias
12/09
12/09
NCT01092663: The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus

Completed
N/A
61
US
Colesevelam HCl, Welchol, Sitagliptin, Januvia
KineMed
Diabetes Mellitus, Type 2
07/11
07/11
NCT01666223: Effect of Bile Acids on GLP-1 Secretion

Completed
N/A
20
Europe
Colesevelam, Chenodeoxycholic Acid, saline, Colesevelam 3750 mg + chenodeoxycholic acid 1250 mg
University Hospital, Gentofte, Copenhagen
Type 2 Diabetes, Obesity
06/13
06/13

Download Options